Arlington Massachusetts based Revere Pharmaceuticals is raising $3,454,842.00 in Equity Investment.
Arlington, MA – According to filings with the U.S. Securities and Exchange Commission, Revere Pharmaceuticals is raising $3,454,842.00 in new funding. Sources indicate as part of senior management President, Robert Silverman played a key role…
